Clinical Trial Update: A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems [Phase 1]

View source ↗

Summary

Phase 1 study to assess how BI 3000202 is absorbed into the bloodstream in healthy individuals and in people with hepatic impairment; recruitment has not yet st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• BI 3000202

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Hepatic Impairment | Phase 1 | Status: NOT_YET_RECRUITING